$TECH

AI Analysis

Generated on May 11, 2026

AI Score
66/ 100
Hold$TECH

Bio-Techne Corporation

$TECHNASDAQHealthcareMid-Cap

Bio-Techne develops and sells biotechnology instruments and reagents for life science research and clinical diagnostics.

Market Cap
$10.0B
Revenue (TTM)
$1.1B
+3.0%
Net Income (TTM)
$0.2B
+5.0%
EPS (TTM)
$1.25
P/E Ratio
52.0
Dividend Yield
0.3%
52-Week Range
$55-$82
Beta
0.92
Dimension Scores
Fundamental
64
Technical
62
Sentiment
68
Risk / Reward
66
Momentum
64
FundTechSentRiskMome
Financial Health
Profitability
69moderate
Growth
67moderate
Liquidity
74strong
Solvency
66strong
Efficiency
62moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $TECH

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.